Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SANA

Sana Biotechnology Inc

Jul 26 • 04:00PM ET

6.40

Dollar change +0.35
Percentage change 5.79	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM XBI VB VBK VXF IWO IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.53	Insider Own	45.59%	Shs Outstand	197.86M	Perf Week	10.34%
Market Cap	1.42B	Forward P/E	-	EPS next Y	-1.17	Insider Trans	5.68%	Shs Float	120.52M	Perf Month	21.90%
Income	-308.61M	PEG	-	EPS next Q	-0.28	Inst Own	50.26%	Short Float	23.13%	Perf Quarter	-24.71%
Sales	0.00M	P/S	-	EPS this Y	15.41%	Inst Trans	1.60%	Short Ratio	14.34	Perf Half Y	19.63%
Book/sh	1.70	P/B	3.78	EPS next Y	5.40%	ROA	-43.21%	Short Interest	27.88M	Perf Year	7.74%
Cash/sh	1.42	P/C	4.50	EPS next 5Y	-	ROE	-76.82%	52W Range	2.74 - 12.00	Perf YTD	56.86%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-83.13%	ROI	-65.93%	52W High	-46.67%	Beta	1.42
Dividend TTM	-	Quick Ratio	6.07	Sales past 5Y	0.00%	Gross Margin	-	52W Low	133.15%	ATR (14)	0.47
Dividend Ex-Date	-	Current Ratio	6.07	EPS Y/Y TTM	9.45%	Oper. Margin	0.00%	RSI (14)	54.33	Volatility	6.91% 7.16%
Employees	328	Debt/Eq	0.28	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.67	Target Price	12.80
Option/Short	Yes / Yes	LT Debt/Eq	0.25	EPS Q/Q	-15.18%	Payout	-	Rel Volume	0.70	Prev Close	6.05
Sales Surprise	-	EPS Surprise	-62.52%	Sales Q/Q	-	Earnings	May 08 AMC	Avg Volume	1.94M	Price	6.40
SMA20	11.31%	SMA50	-3.60%	SMA200	0.26%	Trades		Volume	1,357,885	Change	5.79%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-26-24	Initiated	Rodman & Renshaw	Buy	$16
Jan-16-24	Upgrade	H.C. Wainwright	Neutral → Buy	$12
Sep-25-23	Initiated	JMP Securities	Mkt Outperform	$9
Sep-05-23	Initiated	Citigroup	Buy	$8
Aug-14-23	Initiated	TD Cowen	Market Perform
May-02-23	Initiated	H.C. Wainwright	Neutral
Mar-01-21	Initiated	Morgan Stanley	Overweight	$40
Mar-01-21	Initiated	JP Morgan	Neutral	$35
Mar-01-21	Initiated	Goldman	Neutral	$40
Mar-01-21	Initiated	BofA Securities	Buy	$45

Jul-25-24 08:00AM	Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World (PR Newswire)
Jul-23-24 06:00AM	Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class (PR Newswire)
Jul-17-24 08:00AM	Alltrna Announces Updates to Its Board of Directors (PR Newswire) -7.00%
Jul-10-24 06:00AM	Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability (PR Newswire)
06:00AM	Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions (PR Newswire)
07:00AM	Loading…
Jun-12-24 07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
May-21-24 09:00AM	Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington's Disease and Other Glial-based Neurodegenerative Conditions (GlobeNewswire)
May-16-24 05:23PM	Stanley Druckenmiller Bet On Biotech, Financial Services in Q1, Trimmed Nvidia Stake (Investopedia) -7.77%
May-10-24 01:35PM	Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:00AM	Flagship Pioneering and Metaphore Biotechnologies Announce Research Collaboration with Novo Nordisk to Develop Next-Generation Therapeutics for Obesity Management (PR Newswire) -20.97%
May-08-24 10:55PM	SANA Stock Earnings: Sana Biotechnology Meets EPS for Q1 2024 (InvestorPlace) -5.48%
05:22PM	Sana: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates (GlobeNewswire)
May-06-24 04:05PM	Sana Biotechnology to Present at May and June 2024 Investor Conferences (GlobeNewswire)
Apr-08-24 08:00AM	Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
10:00AM	Loading…
Mar-19-24 10:00AM	CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB) (GlobeNewswire)
08:30AM	Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (PR Newswire)
Mar-11-24 07:00PM	Director Patrick Yang Sells 25,000 Shares of Sana Biotechnology Inc (SANA) (GuruFocus.com)
Mar-07-24 09:01AM	Baillie Gifford Bolsters Stake in Sana Biotechnology Inc (GuruFocus.com)
Feb-29-24 04:55PM	Sana: Q4 Earnings Snapshot (Associated Press Finance) -5.90% +12.25%
04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates (GlobeNewswire)
03:02AM	14 Stocks With Heavy Insider Buying In 2024 (Insider Monkey)
Feb-28-24 04:05PM	Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference (GlobeNewswire) +7.34%
Feb-13-24 04:05PM	Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHP (GlobeNewswire) +15.15%
Feb-12-24 04:05PM	Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Feb-08-24 01:22AM	Sana Biotechnology Announces Pricing of Upsized Public Offering (GlobeNewswire)
Feb-07-24 04:01PM	Sana Biotechnology Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Jan-27-24 11:02AM	Baillie Gifford Reduces Stake in Sana Biotechnology Inc (GuruFocus.com)
Jan-18-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Sana Biotechnology (SANA) is a Great Choice (Zacks) -7.68%
10:24AM	Sana Bio (SANA) Stock Rallies 105% in 3 Months: Here's Why (Zacks)
08:44AM	Loading…
Jan-09-24 08:44AM	DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING (PR Newswire)
Jan-08-24 06:30AM	Flagship Pioneering Debuts Enabling Technologies Initiative (PR Newswire)
06:30AM	Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine (PR Newswire)
Jan-05-24 09:00AM	Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC262, a Hypoimmune-modified, CD22-directed Allogeneic CAR T Therapy, for Patients with Relapsed or Refractory B-cell Malignancies (GlobeNewswire)
Jan-03-24 04:05PM	Sana Biotechnology to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +11.90%
Dec-19-23 09:01AM	EVP Christian Hordo Sells 75,000 Shares of Sana Biotechnology Inc (SANA) (GuruFocus.com) +13.60%
Dec-11-23 09:00AM	Sana Biotechnology Highlights Preclinical Data Supporting Tumor Control and Immune Evasion Capabilities of Hypoimmune-Modified Allogeneic CAR T Cells in Presentations at the American Society of Hematology Annual Meeting (GlobeNewswire)
Dec-01-23 04:05PM	Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System (GlobeNewswire)
Nov-27-23 07:01PM	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders (PR Newswire)
Nov-21-23 09:00AM	Sana Biotechnology to Present at November and December 2023 Investor Conferences (GlobeNewswire) -6.74%
06:00AM	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics (PR Newswire)
Nov-17-23 09:00AM	Uppsala University Hospital and Sana Biotechnology Announce Authorization of the First-in-Human Clinical Trial Application for a Primary Islet Cell Treatment for Patients with Type 1 Diabetes (GlobeNewswire) +7.14%
Nov-09-23 04:05PM	Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-directed Allogeneic CAR T Therapy, for Patients with Lupus Nephritis, Extrarenal Lupus, and ANCA-associated Vasculitis (GlobeNewswire)
Nov-08-23 04:05PM	Sana Biotechnology Reports Third Quarter 2023 Financial Results and Business Updates (GlobeNewswire) -13.92%
Nov-02-23 09:05AM	Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting (GlobeNewswire)
Nov-01-23 10:30AM	Flagship Pioneering Launches Pioneering Intelligence (PR Newswire)
Oct-19-23 10:30AM	Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines (PR Newswire)
Oct-10-23 04:15PM	Sana Biotechnology Announces Increased Focus on Hypoimmune-Related Pipeline with the Potential to Deliver Clinical Proof of Concept Data from Four Programs in 2023 and 2024 with a 2024 Operating Burn under $200M (GlobeNewswire) -8.95%
Oct-02-23 07:00AM	Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics (PR Newswire) -7.49%
Sep-27-23 08:31AM	Flagship Pioneering Named to Fortune's 2023 'Change the World' List (PR Newswire) +5.31%
Sep-11-23 06:30AM	Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer (PR Newswire)
Aug-30-23 04:05PM	Sana Biotechnology to Present at September 2023 Investor Conferences (GlobeNewswire)
Aug-29-23 09:00AM	Invaio achieves first registration for citrus greening solution featuring Trecise technology (PR Newswire)
Aug-03-23 05:03PM	Sana: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Sana Biotechnology Reports Second Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
Jun-16-23 09:00AM	Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023 Annual Meeting (GlobeNewswire)
May-31-23 04:05PM	Sana Biotechnology to Present at June 2023 Investor Conferences (GlobeNewswire)
May-22-23 07:33AM	Weekly biotech pulse: Sana, aTyr, Theseus to release fresh data (Investing.com) +5.76%
May-16-23 06:00AM	Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry (PR Newswire)
May-08-23 04:35PM	Sana Biotechnology Announces Preclinical Data Published in Nature Biotechnology Demonstrating its Hypoimmune-Engineered Cells Escape Immune Detection and Survive While Remaining Fully Functional (GlobeNewswire) +10.29%
04:26PM	Sana: Q1 Earnings Snapshot (AP Finance)
04:05PM	Sana Biotechnology Reports First Quarter 2023 Financial Results and Business Updates (GlobeNewswire)
May-04-23 01:56PM	7 High-Potential Penny Stocks in the Biotech Sector (InvestorPlace)
May-03-23 04:05PM	Sana Biotechnology to Present at May 2023 Investor Conferences (GlobeNewswire) +8.91%
09:55AM	Wall Street Analysts Believe Sana (SANA) Could Rally 83.17%: Here's is How to Trade (Zacks)
May-02-23 04:30PM	Sana Biotechnology Announces the Acceptance of Six Abstracts for Presentation at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting (GlobeNewswire) -7.68%
12:50PM	Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth? (Simply Wall St.)
Apr-24-23 04:05PM	Sana Biotechnology to Host Research & Development Day (GlobeNewswire)
Apr-20-23 10:07AM	The Top 3 Biotech Stocks to Watch in 2023 (InvestorPlace) -8.59%
Apr-19-23 04:05PM	Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with Four Presentations at the 2023 AACR Annual Meeting (GlobeNewswire)
Apr-17-23 09:55AM	Does Sana (SANA) Have the Potential to Rally 78.23% as Wall Street Analysts Expect? (Zacks) +8.67%
06:17AM	2 Growth Stocks That Jumped 42% and 58% Last Week: Can They Still Climb Higher? (Motley Fool)
Apr-14-23 10:27AM	Why Shares of Sana Biotechnology Jumped This Week (Motley Fool) +5.92%
Apr-13-23 09:00AM	Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses (GlobeNewswire) +30.67%
Apr-12-23 04:05PM	Sana Biotechnology Announces Preclinical Data Published in Science Translational Medicine Showing its Hypoimmune Pancreatic Islet Cells Evaded Allogeneic and Autoimmune Rejection and Controlled Type 1 Diabetes in Preclinical Model (GlobeNewswire)
Apr-10-23 04:05PM	Sana Biotechnology Announces the Appointment of Two Pioneers in Drug Discovery and Development to Lead its R&D Organization (GlobeNewswire) +11.28%
Mar-24-23 03:20PM	Jeff Bezos Stock Portfolio: 10 Companies and Startups (Insider Monkey)
Mar-16-23 04:05PM	Sana Biotechnology Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +7.36%
Mar-14-23 04:53PM	Sana Biotechnology Announces the Acceptance of Four Abstracts for Presentation at the 2023 American Association for Cancer Research Annual Meeting (GlobeNewswire)
Mar-01-23 04:05PM	Sana Biotechnology to Present at the Cowen 43rd Annual Health Care Conference (GlobeNewswire)
Feb-10-23 08:18AM	Insiders who purchased this year lose US$82k as Sana Biotechnology, Inc. (NASDAQ:SANA) stock drops to US$4.36 (Simply Wall St.)
Feb-02-23 04:05PM	Sana Biotechnology to Present at the Guggenheim Healthcare Talks 5th Annual Oncology Conference (GlobeNewswire)
Jan-26-23 04:05PM	Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies (GlobeNewswire)
Jan-03-23 04:05PM	Sana Biotechnology to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.57% +7.77%
Dec-11-22 05:30PM	Sana Biotechnology Highlights Hypoimmune Allogeneic CAR T Cell Programs and in vivo Technology Platform with Six Presentations at 2022 ASH Annual Meeting (GlobeNewswire)
Dec-01-22 12:11AM	Sana Biotechnology to lay off 15% of its employees (American City Business Journals) -11.22%
Nov-30-22 10:55AM	Once valued at $6 billion, Sana Biotechnology plans to cut 15% of workforce (American City Business Journals) +5.94%
08:43AM	Sana Biotechnology Outlines Pipeline Prioritization, Reduces Workforce (Benzinga)
Nov-29-22 04:05PM	Sana Biotechnology Confirms Key Program Timelines and Announces Portfolio Prioritization (GlobeNewswire)
Nov-17-22 01:58PM	Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies (Insider Monkey)
Nov-14-22 04:05PM	Sana Biotechnology Tops BioSpaces 2023 Best Places to Work Ranking in Small Employer Category (GlobeNewswire) -7.04%
Nov-03-22 09:07AM	Sana Biotechnology Announces Several Preclinical Data Presentations at the 64th American Society of Hematology Annual Meeting (GlobeNewswire) -13.94%
Nov-02-22 04:05PM	Sana Biotechnology Reports Third Quarter 2022 Financial Results and Business Updates (GlobeNewswire)
Oct-18-22 07:43AM	We're Keeping An Eye On Sana Biotechnology's (NASDAQ:SANA) Cash Burn Rate (Simply Wall St.)
Sep-09-22 04:05PM	Sana Biotechnology to Present at September 2022 Investor Conferences (GlobeNewswire)
Sep-03-22 08:39AM	Insiders who bought in the last 12 months lose an additional US$22k as Sana Biotechnology, Inc. (NASDAQ:SANA) drops to US$1.2b (Simply Wall St.)
Aug-09-22 11:54AM	7 Stocks Due for a Stunning Short Squeeze (InvestorPlace) -6.90%
Aug-04-22 04:05PM	Sana Biotechnology Reports Second Quarter 2022 Financial Results and Business Updates (GlobeNewswire) +10.10% +11.07%
Jun-17-22 09:00AM	Sana Biotechnology Presents Data at ISSCR 2022 Annual Meeting Showing Survival of Transplanted Hypoimmune iPSC-Derived Differentiated Cell Types Without Immunosuppression in Non-Human Primates (GlobeNewswire) +21.46%
Jun-13-22 04:05PM	Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the Upcoming ISSCR 2022 Annual Meeting (GlobeNewswire) -10.54%

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yang Patrick Y	Director	Mar 08 '24	Sale	9.45	25,000	236,300	149,250	Mar 11 04:57 PM
NELSEN ROBERT	Director	Feb 08 '24	Buy	5.50	1,818,181	9,999,996	12,446,022	Feb 12 05:46 PM
ARCH Venture Fund X, L.P.	10% Owner	Feb 08 '24	Buy	5.50	1,818,181	9,999,996	12,446,022	Feb 12 05:43 PM
CRANDELL KEITH	10% Owner	Feb 08 '24	Buy	5.50	1,818,181	9,999,996	12,446,022	Feb 12 05:43 PM
Hordo Christian	EVP, Chief Business Officer	Dec 15 '23	Sale	4.00	75,000	300,098	867,455	Dec 18 04:51 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SANA

Sana Biotechnology Inc

Upgrade your FINVIZ experience